Mechanisms underlying increased serotonin-induced contraction in carotid arteries from chronic type 2 diabetic Goto-Kakizaki rats

Pharmacological Research

Volumn 87, Issue , 2014, Pages 123-132

  Matsumoto, Takayuki ^a   Watanabe, Shun ^a   Taguchi, Kumiko ^a   Kobayashi, Tsuneo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Carotid artery; Contraction; Diabetes; Kinase; Serotonin transporter; Vascular smooth muscle

Indexed keywords

1 [5 (2 THIENYLMETHOXY) 3 INDOLYL] 2 PROPANAMINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CLORGYLINE; FLUVOXAMINE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; RHO KINASE; SEROTONIN; SEROTONIN 2A AGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; TCB 2; UNCLASSIFIED DRUG; AMINE OXIDASE (FLAVIN CONTAINING); MONOAMINE OXIDASE INHIBITOR; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; RNA BINDING PROTEIN; SERT PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CAROTID ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; GOTO KAKIZAKI RAT; IMMUNOBLOTTING; MALE; MUSCLE ISOMETRIC CONTRACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; STRAIN DIFFERENCE; WISTAR RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; IN VITRO STUDY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASOCONSTRICTION;

ANIMALS; CAROTID ARTERIES; CLORGYLINE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; IN VITRO TECHNIQUES; MALE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; RNA-BINDING PROTEINS; SEROTONIN; VASOCONSTRICTION;

EID: 84904969131     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2014.07.001     Document Type: Article

References (41)

1. L.F. Van Gaal, I.L. Mertens, and C.E. De Block Mechanisms linking obesity with cardiovascular disease Nature 444 2006 875 880 (Pubitemid 46028447)
2. J.M. Forbes, and M.E. Cooper Mechanisms of diabetic complications Physiol Rev 93 2013 137 188
3. K.S. Polonsky The past 200 years in diabetes N Engl J Med 367 2012 1332 1340
4. T. Matsumoto, K. Ishida, N. Nakayama, K. Taguchi, T. Kobayashi, and K. Kamata Mechanisms underlying the losartan treatment-induced improvement in the endothelial dysfunction seen in mesenteric arteries from type 2 diabetic rats Pharmacol Res 62 2010 271 281
5. K. Taguchi, T. Matsumoto, K. Kamata, and T. Kobayashi Angiotensin II type 2 receptor-dependent increase in nitric oxide synthase activity in the endothelium of db/db mice is mediated via a MEK pathway Pharmacol Res 66 2012 41 50
6. K. Taguchi, T. Koayashi, Y. Takenouchi, T. Matsumoto, and K. Kamata Angiotensin II causes endothelial dysfunction via the GRK2/Akt/eNOS pathway in aortas from murine type 2 diabetic model Pharmacol Res 64 2011 535 546
7. K.E. Porter, and K. Riches The vascular smooth muscle cell: a therapeutic target in type 2 diabetes Clin Sci 125 2013 167 182
8. T. Matsumoto, K. Ishida, N. Nakayama, T. Kobayashi, and K. Kamata Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat Am J Physiol Heart Circ Physiol 296 2009 H1388 H1397
9. T. Matsumoto, T. Kobayashi, K. Ishida, K. Taguchi, and K. Kamata Enhancement of mesenteric artery contraction to 5-HT depends on Rho kinase and Src kinase pathways in the ob/ob mouse model of type 2 diabetes Br J Pharmacol 160 2010 1092 1104
10. T. Matsumoto, S. Watanabe, R. Kawamura, K. Taguchi, and T. Kobayashi Enhanced uridine adenosine tetraphosphate-induced contraction in renal artery from type 2 diabetic Goto-Kakizaki rats due to activated cyclooxygenase/ thromboxane receptor axis Pflugers Arch 466 2014 331 342
11. T. Matsumoto, S. Watanabe, R. Kawamura, K. Taguchi, and T. Kobayashi Epigallocatechin gallate attenuates ET-1-induced contraction in carotid artery from type 2 diabetic OLETF rat at chronic stage of disease Life Sci 2013 10.1016/j.lfs.2013.11.016 [pii: S0024-3205(13)00738-8, Epub ahead of print]
12. K. Srinivasan, and P. Ramarao Animal models in type 2 diabetes research: an overview Indian J Med Res 125 2007 451 472 (Pubitemid 46805458)
13. Y. Goto, M. Kakizaki, and N. Masaki Production of spontaneous diabetic rats by repetition of selective breeding Tohoku J Exp Med 119 1976 85 90
14. M. Radenkovic, M. Stojanovic, and M. Topalovic Contribution of thromboxane A2 in rat common carotid artery response to serotonin Sci Pharm 78 2010 435 443
15. S.W. Watts The love of a lifetime: 5-HT in the cardiovascular system Am J Physiol Regul Integr Comp Physiol 296 2009 R252 R256
16. S.W. Watts, S.F. Morrison, R.P. Davis, and S.M. Barman Serotonin and blood pressure regulation Pharmacol Rev 64 2012 359 388
17. E.E. Billett Monoamine oxidase (MAO) in human peripheral tissues Neurotoxicology 25 2004 139 148 (Pubitemid 38044175)
18. W. Ni, and S.W. Watts 5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT) Clin Exp Pharmacol Physiol 33 2006 575 583 (Pubitemid 43894017)
19. S.W. Seto, H.Y. Lam, W.S. Lau, A.L. Au, T.Y. Lam, and S.S. Chim et al. Role of monoamine oxidases in the exaggerated 5-hydroxytryptamine-induced tension development of human isolated preeclamptic umbilical artery Eur J Pharmacol 605 2009 129 137
20. A.E. Linder, R.P. Davis, R. Burnett, and S.W. Watts Comparison of the function of the serotonin transporter in the vasculature of male and female rats Clin Exp Pharmacol Physiol 38 2011 314 322
21. R.R. Gainetdinov, and M.G. Caron Monoamine transporters: from genes to behavior Annu Rev Pharmacol Toxicol 43 2003 261 284 (Pubitemid 37372642)
22. W. Ni, T.J. Geddes, J.R. Priestley, T. Szasz, D.M. Kuhn, and S.W. Watts The existence of a local 5-hydroxytryptaminergic system in peripheral arteries Br J Pharmacol 154 2008 663 674 (Pubitemid 351744942)
23. G.R. De Meyer, H. Bult, L. Ustunes, M. Kockx, F.H. Jordaens, and L.L. Zonnekeyn et al. Vasoconstrictor responses after neo-intima formation and endothelial removal in the rabbit carotid artery Br J Pharmacol 112 1994 471 476 (Pubitemid 24172887)
24. F.J. Miranda, J.A. Alabadi, S. Llorens, R.F. Ruiz de Apodaca, J.M. Centeno, and E. Alborch Diabetes-induced changes in endothelial mechanisms implicated in rabbit carotid arterial response to 5-hydroxytryptamine Eur J Pharmacol 401 2000 397 402 (Pubitemid 30608725)
25. C.C. Poon, S.W. Seto, A.L. Au, Q. Zhang, R.W. Li, and W.Y. Lee et al. Mitochondrial monoamine oxidase-A-mediated hydrogen peroxide generation enhances 5-hydroxytryptamine-induced contraction of rat basilar artery Br J Pharmacol 161 2010 1086 1098
26. W. Ni, J.M. Thompson, C.A. Northcott, K. Lookingland, and S.W. Watts The serotonin transporter is present and functional in peripheral arterial smooth muscle J Cardiovasc Pharmacol 43 2004 770 781 (Pubitemid 38679598)
27. K. Tasaki, M. Hori, H. Ozaki, H. Karaki, and I. Wakabayashi Difference in signal transduction mechanisms involved in 5-hydroxytryptamine- and U46619-induced vasoconstrictions J Smooth Muscle Res 39 2003 107 117 (Pubitemid 38017639)
28. K. Kamata, N. Kanie, T. Matsumoto, and T. Kobayashi Endothelin-1-induced impairment of endothelium-dependent relaxation in aortas isolated from controls and diabetic rats J Cardiovasc Pharmacol 44 2004 S186 S190
29. D.W. Nuno, V.P. Korovkina, S.K. England, and K.G. Lamping Rho A activation contributes to sex differences in vascular contractions Arterioscler Thromb Vasc Biol 27 2007 1934 1940 (Pubitemid 47312301)
30. K. Kazama, M. Okada, and H. Yamawaki A novel adipokine, omentin, inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell migration through anti-oxidative mechanism Am J Physiol Heart Circ Physiol 306 2014 H1714 H1719
31. R.A. Khalil, and C. Breemen Mechanisms of calcium mobilization and homeostasis in vascular smooth muscle and their relevance to hypertension J.H. Laragh, B.M. Brenner, Hypertension: Pathophysiology, Diagnosis and Management 1995 Raven Press New York 523 540
32. P.M. Nelson, J.S. Harrod, and K.G. Lamping 5HT(2A) and 5HT(2B) receptors contribute to serotonin-induced vascular dysfunction in diabetes Exp Diabetes Res 2012 2012 398406
33. A. Banes, J.A. Florian, and S.W. Watts Mechanisms of 5- hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle J Pharmacol Exp Ther 291 1999 1179 1187
34. S.W. Watts Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension Hypertension 39 2002 825 829 (Pubitemid 34252884)
35. P.M. Vanhoutte, H. Shimokawa, E.H. Tang, and M. Feletou Endothelial dysfunction and vascular disease Acta Physiol 196 2009 193 222
36. S.F. Nunes, I.V. Figueiredo, J.S. Pereira, E.T. de Lemos, F. Reis, and F. Teixeira et al. Monoamine oxidase and semicarbazide-sensitive amine oxidase kinetic analysis in mesenteric arteries of patients with type 2 diabetes Physiol Res 60 2011 309 315
37. S. Eddahibi, V. Fabre, C. Boni, M.P. Martres, B. Raffestin, and M. Hamon et al. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells Circ Res 84 1999 329 336
38. S. Eddahibi, M. Humbert, E. Fadel, B. Raffestin, M. Darmon, and F. Capron et al. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension J Clin Invest 108 2001 1141 1150 (Pubitemid 32995372)
39. W. Ni, K. Lookingland, and S.W. Watts Arterial 5-hydroxytryptamine transporter function is impaired in deoxycorticosterone acetate and Nomega-nitro-l-arginine but not spontaneously hypertensive rats Hypertension 48 2006 134 140 (Pubitemid 44297535)
40. P. Sobieszczyk, and J. Beckman Carotid artery disease Circulation 114 2006 e244 e247
41. M.K. Poulsen, J.E. Henriksen, J. Dahl, A. Johansen, J.E. Moller, and O. Gerke et al. Myocardial ischemia, carotid, and peripheral arterial disease and their interrelationship in type 2 diabetes patients J Nucl Cardiol 16 2009 878 887